Case Report: Good cardiac tolerance to Toripalimab in a CVD patient with oral melanoma

Conclusions: This case provided evidence of Toripalimab combined with chemotherapy on melanoma patients with complex cardiovascular diseases. Toripalimab demonstrated a manageable safety profile and durable clinical response. In addition, the standard CHF treatment plays a vital role in the protection of cardiac function. In a cancer patient with complex cardiovascular diseases, standard prophylactic CHF treatment should be applied at an early stage.PMID:35979233 | PMC:PMC9376878 | DOI:10.3389/fphar.2022.890546
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research